ImmunoGen’s Elahere Data In Avastin-Naïve Ovarian Cancer Prompt Discussion About Earlier Use

The presenter on the MIRASOL study called the data “practice changing,” while the discussant cited Sutro’s STRO-002 as a potential option for patients with low folate receptor alpha expression.

Chicago's McCormick Place during the 2023 ASCO meeting • Source: Alaric DeArment

More from ASCO

More from Conferences